Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
18.79
+0.10 (0.54%)
Nov 17, 2026, 3:04 PM CST

SHE:002287 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
122.74376.44189.59403.43437.57666.63
Short-Term Investments
-91.56--224.65107.74
Trading Asset Securities
2,4312,5722,8071,9631,5391,184
Cash & Short-Term Investments
2,5533,0402,9972,3662,2021,958
Cash Growth
-15.51%1.43%26.64%7.49%12.42%6.98%
Accounts Receivable
715.93901.93942.91604.86825.39606.61
Other Receivables
5.853.226.1818.3410.03212.89
Receivables
721.78905.16949.09623.19835.42819.49
Inventory
302.96294.11185.33156.33127.77118.5
Prepaid Expenses
-0.120.091.116.881.99
Other Current Assets
151.168.9622.947.2520.8338.07
Total Current Assets
3,7294,3084,1543,1943,1922,936
Property, Plant & Equipment
1,7301,6961,6951,6471,144821.35
Long-Term Investments
547.72557.71561.241,0431,1161,357
Other Intangible Assets
283.49303.29325.5351.62374.81399.33
Long-Term Deferred Tax Assets
37.8340.4536.0239.3930.5926.68
Long-Term Deferred Charges
6.635.573.924.953.295.25
Other Long-Term Assets
277.094.7214.7917.6826.3321.28
Total Assets
6,6126,9166,7906,2985,8885,568

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
84.83204.74235.44266.2393.47184
Accrued Expenses
72.96346.74366.76352.86330.7297.27
Short-Term Debt
881.1915.55813.01451.52701.73501.81
Current Portion of Long-Term Debt
11.642.580.289.0254.11103.93
Current Portion of Leases
-4.95.346.396.475.07
Current Income Taxes Payable
49.7338.2818.855.5625.99.83
Current Unearned Revenue
101.81134.24110.0273.89102.16110.11
Other Current Liabilities
103.0631.634.9729.7445.5995.96
Total Current Liabilities
1,3051,6791,6651,2451,3601,308
Long-Term Debt
253.45797.81,061929.47836.48
Long-Term Leases
3.333.451.6874.914.94
Long-Term Unearned Revenue
203.54208.94184.14191.3167.04154.66
Long-Term Deferred Tax Liabilities
23.4323.6926.2820.9436.3940.71
Other Long-Term Liabilities
2.62.62.62.62.62.6
Total Liabilities
1,5631,9212,6772,5282,5012,347

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
572.12572.12531.09530.19530.22530.3
Additional Paid-In Capital
1,4061,403495.02477.25476.33480.44
Retained Earnings
3,1533,1092,9042,5762,2022,042
Treasury Stock
-124.81-137.45--0.48-8.68-16.97
Comprehensive Income & Other
-3.610.69134.35137.25136.4133.14
Total Common Equity
5,0034,9484,0643,7203,3363,169
Minority Interest
45.9147.9348.9449.8251.6451.35
Shareholders' Equity
5,0494,9964,1133,7703,3883,220
Total Liabilities & Equity
6,6126,9166,7906,2985,8885,568

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
921.07929.841,6981,5351,6971,452
Net Cash (Debt)
1,6322,1101,299831.28504.82506.11
Net Cash Growth
-19.78%62.46%56.24%64.67%-0.26%-18.75%
Net Cash Per Share
2.883.882.451.570.950.96
Filing Date Shares Outstanding
566.88566.88530.03530.19529.64528.63
Total Common Shares Outstanding
566.88566.88531.09530.19529.64528.63
Working Capital
2,4242,6302,4901,9491,8321,628
Book Value Per Share
8.828.737.657.026.305.99
Tangible Book Value
4,7194,6443,7393,3692,9612,770
Tangible Book Value Per Share
8.328.197.046.355.595.24
Buildings
-1,3891,3561,309705.16671.59
Machinery
-446.28425.39328.81190.32181.58
Construction In Progress
-344.23294.56302.75533.08212.04